Literature DB >> 10205271

A new locus for autosomal dominant stargardt-like disease maps to chromosome 4.

M Kniazeva1, M F Chiang, B Morgan, A L Anduze, D J Zack, M Han, K Zhang.   

Abstract

Stargardt disease (STGD) is the most common hereditary macular dystrophy and is characterized by decreased central vision, atrophy of the macula and underlying retinal-pigment epithelium, and frequent presence of prominent flecks in the posterior pole of the retina. STGD is most commonly inherited as an autosomal recessive trait, but many families have been described in which features of the disease are transmitted in an autosomal dominant manner. A recessive locus has been identified on chromosome 1p (STGD1), and dominant loci have been mapped to both chromosome 13q (STGD2) and chromosome 6q (STGD3). In this study, we describe a kindred with an autosomal dominant Stargardt-like phenotype. A genomewide search demonstrated linkage to a locus on chromosome 4p, with a maximum LOD score of 5.12 at a recombination fraction of.00, for marker D4S403. Analysis of extended haplotypes localized the disease gene to an approximately 12-cM interval between loci D4S1582 and D4S2397. Therefore, this kindred establishes a new dominant Stargardt-like locus, STGD4.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205271      PMCID: PMC1377876          DOI: 10.1086/302377

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

1.  Fundus flavimaculatus and Stargardt's disease.

Authors:  O B Hadden; J D Gass
Journal:  Am J Ophthalmol       Date:  1976-10       Impact factor: 5.258

2.  Sequential tests for the detection of linkage.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1955-09       Impact factor: 11.025

3.  Nucleotide sequence and regulation of a human 90-kDa heat shock protein gene.

Authors:  N F Rebbe; W S Hickman; T J Ley; D W Stafford; S Hickman
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

4.  Stargardt's disease and fundus flavimaculatus.

Authors:  K G Noble; R E Carr
Journal:  Arch Ophthalmol       Date:  1979-07

5.  The dark choroid in posterior retinal dystrophies.

Authors:  G Fish; R Grey; K S Sehmi; A C Bird
Journal:  Br J Ophthalmol       Date:  1981-05       Impact factor: 4.638

6.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

Review 7.  Pathophysiology of age-related macular degeneration.

Authors:  R W Young
Journal:  Surv Ophthalmol       Date:  1987 Mar-Apr       Impact factor: 6.048

8.  Dominantly inherited macular dystrophy with flecks (Stargardt).

Authors:  G W Cibis; M Morey; D J Harris
Journal:  Arch Ophthalmol       Date:  1980-10

Review 9.  Age-related macular degeneration.

Authors:  N M Bressler; S B Bressler; S L Fine
Journal:  Surv Ophthalmol       Date:  1988 May-Jun       Impact factor: 6.048

10.  Autosomal-dominant fundus flavimaculatus. Clinicopathologic correlation.

Authors:  P F Lopez; I H Maumenee; Z de la Cruz; W R Green
Journal:  Ophthalmology       Date:  1990-06       Impact factor: 12.079

View more
  29 in total

Review 1.  Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein.

Authors:  Martin-Paul Agbaga; Md Nawajes A Mandal; Robert E Anderson
Journal:  J Lipid Res       Date:  2010-03-18       Impact factor: 5.922

2.  Examination of VLC-PUFA-deficient photoreceptor terminals.

Authors:  Lea D Bennett; Blake R Hopiavuori; Richard S Brush; Michael Chan; Matthew J Van Hook; Wallace B Thoreson; Robert E Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-24       Impact factor: 4.799

Review 3.  Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations.

Authors:  Frans P M Cremers; Winston Lee; Rob W J Collin; Rando Allikmets
Journal:  Prog Retin Eye Res       Date:  2020-04-09       Impact factor: 21.198

Review 4.  Molecular genetics of macular degeneration.

Authors:  M A Musarella
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

Review 5.  Genotype-phenotype correlations and differential diagnosis in autosomal dominant macular disease.

Authors:  A Iannaccone
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

6.  A novel locus on 19q13 associated with autosomal-dominant macular dystrophy in a large Greek family.

Authors:  Z Yang; G Kitsos; Z Tong; M Payne; S Gorezis; K Psilas; M Grigoriadou; Y Zhao; S Kamaya; G Aperis; M B Petersen; K Zhang
Journal:  J Med Genet       Date:  2006-12       Impact factor: 6.318

7.  The PROM1 mutation p.R373C causes an autosomal dominant bull's eye maculopathy associated with rod, rod-cone, and macular dystrophy.

Authors:  Michel Michaelides; Marie-Claire Gaillard; Pascal Escher; Leila Tiab; Matthew Bedell; François-Xavier Borruat; Daniel Barthelmes; Ruben Carmona; Kang Zhang; Edward White; Michelle McClements; Anthony G Robson; Graham E Holder; Keith Bradshaw; David M Hunt; Andrew R Webster; Anthony T Moore; Daniel F Schorderet; Francis L Munier
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-14       Impact factor: 4.799

8.  A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration.

Authors:  A Rivera; K White; H Stöhr; K Steiner; N Hemmrich; T Grimm; B Jurklies; B Lorenz; H P Scholl; E Apfelstedt-Sylla; B H Weber
Journal:  Am J Hum Genet       Date:  2000-08-24       Impact factor: 11.025

Review 9.  The genetics of inherited macular dystrophies.

Authors:  M Michaelides; D M Hunt; A T Moore
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

10.  Novel ABCA4 compound heterozygous mutations cause severe progressive autosomal recessive cone-rod dystrophy presenting as Stargardt disease.

Authors:  Quansheng Xi; Lin Li; Elias I Traboulsi; Qing Kenneth Wang
Journal:  Mol Vis       Date:  2009-04-03       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.